We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Subcutaneous versus intravenous administration of Trastuzumab: a minimization cost analysis with real world data from a reference cancer centre in Peru.
- Authors
Otoya, Iris; Valdiviezo, Natalia; Roque, Katia; Morante, Zaida; Vidaurre, Tatiana; Neciosup, Silvia P.; Calderón, Mónica J.; Gomez, Henry L.
- Abstract
Breast cancer (BC) is a global concern, with Peru experiencing a high incidence and mortality. Trastuzumab, a crucial treatment for human epidermal growth factor receptor 2-positive BC, is administered intravenously or subcutaneously (SC). This study evaluates the costs associated with both methods at Peru's Instituto Nacional de Enfermedades Neoplásicas. Real data indicate that SC administration reduces treatment costs by approximately S/15,049.09. Cross-continental comparisons highlight a global trend favouring SC administration for efficiency and cost-effectiveness. The analysis provides insights for informed decision-making in resource-constrained healthcare settings like Peru, emphasising the need to consider local contexts in optimising oncology care.
- Subjects
EPIDERMAL growth factor receptors; COST analysis; CANCER treatment; INTRAVENOUS therapy; BREAST cancer
- Publication
Ecancermedicalscience, 2024, Vol 18, Issue 1676-1753, p1
- ISSN
1754-6605
- Publication type
Article
- DOI
10.3332/ecancer.2024.1708